← Evidence map

ArticleOncotarget2016

Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival.

Kai Hung Tiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

51 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27192118